Addiction is a treatable recurring chronic disease.
Amygdala Neurosciences is a biopharmaceutical company whose mission is to invent and develop first-in-class medicines to treat substance use disorders (SUD).
Leading the discovery and development of ALDH2 inhibitors for substance use disorders.
Helping patients escape cravings due to addiction
Addiction is compulsive drug seeking behavior in spite of the negative consequences.